Navigation Links
Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress
Date:11/6/2008

2

TOTAL $ 19,989 $ 35,602

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Accounts payable $ 1,058 $ 2,732

Accrued liabilities 2,040 1,916

Current portion of long-term debt 3,216 3,200

Current portion of capital lease

obligations 27 25

Total current liabilities 6,341 7,873

Long-term debt -less current portion 1,288 3,569

Capital lease obligations 62 82

Other liabilities 49 66

Total liabilities 7,740 11,590

Commitments and Contingencies

Shareholders' Equity:

Preferred stock, $0.0001 par

value -- 1,000,000 shares authorized;

no shares issued or outstanding - -

Common stock, $0.0001 par value --

75,000,000 shares authorized;

21,076,134 and 18,253,500 shares issued

and outstanding at September 30, 2008

and December 31, 2007, respectively 2 2

Additional paid-in capital 125,567 122,237

Accumulated deficit (113,320) (98,227)

Total shareholders' equity 12,249 24,012

TOTAL $ 19,989 $ 35,602


'/>"/>
SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
2. Alsius Corporation Announces Program for Early Exercise of Warrants
3. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
4. Alsius Corporation Receives Regulatory Approval in China and Mexico
5. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
6. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
7. Alsius Corporation Awarded Three-Year Agreement With Premier, Inc.
8. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
9. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
10. Brooke Franchise Corporation Announces Selected July Results
11. MedThink Communications Retained by NanoBio Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, ... dedicated to the provision of quality addiction treatment and the utilization of ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Elizabeth Callahan, MD, ... of the first in the area to offer RADIESSE® filler treatment for volume loss ... the prominence of tendons and veins in the hands, delivering smooth, natural-looking results that ...
(Date:9/1/2015)... ... September 01, 2015 , ... MediNatura™, the exclusive U.S. importer ... physician assistants (PAs) practicing in orthopedics. The workshop, titled “Treatment of Osteoarthritis Knee ... Erick Salado, an orthopedic surgeon at South Florida Bone and Joint Institute, Inc. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Curly Hair ... hair salons. This highly anticipated partnership between Curly Hair Solutions™ and Trade Secrets ... Founder Jonathan Torch and the Curly Hair Solutions™ team could not be more ...
(Date:8/31/2015)... ... August 31, 2015 , ... Jvion, the Atlanta-based leader ... use case focused on helping hospital perform under the Center for Medicare & ... are adjusted based on performance across four domains related to care quality. To ...
Breaking Medicine News(10 mins):Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2
... "The Best Things in Life are FREE!",including an eye exam and ... ... Francisco, CA -- This February, EyeCare America is reminding seniors that ... can,t put a price tag on love, friendship or the importance ...
... PhD, at the University of California, San Diego School ... molecular link between inflammation and cancer has identified ... colitis-associated cancer (CAC), the most serious complication of inflammatory ... Pathology and member of the Moores UCSD Cancer Center, ...
... With dental disease among pre-schoolers on the rise, ... in a national campaign to extend necessary care to ... the seventh annual ADA Give Kids A Smile(R) program, ... as many as 500,000 children at more than 1,600 ...
... says , , MONDAY, Feb. 2 (HealthDay News) -- The sedative ... results in less delirium than other more commonly used drugs ... , For patients in ICUs, delirium is a common side ... affect as many as 85 percent of ICU patients. Some ...
... special MRI technique, researchers have determined that the location and ... can be markedly persistent over time. The findings will be ... , "A considerable number of airways appeared to be consistently ... de Lange, M.D., professor of radiology at the University of ...
... announced FDA approval of an SNM-sponsored centralized multi-center ... (FLT). , The approval of multi-center Chemistry Manufacturing ... the successful demonstration of an important FDA IND ... biomarkers. The FDA has agreed to allow multiple ...
Cached Medicine News:Health News:During February's Valentine's Promotion EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors 2Health News:During February's Valentine's Promotion EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors 3Health News:2 immune-system proteins linked to colitis-associated cancer 2Health News:ADA 'Give Kids A Smile' Events Provide Dental Care to Children from Low-Income Families 2Health News:Newer Sedative May Reduce Delirium in ICU Patients 2Health News:Newer Sedative May Reduce Delirium in ICU Patients 3Health News:Even with medication, asthma patients show chronic airflow changes in lungs 2Health News:FDA embraces a new review process and approves SNM's multi-center IND for FLT 2
(Date:8/31/2015)... SAN FRANCISCO , Aug. 31, 2015  On ... District of Oregon denied motions ... Inc. (NASDAQ: GALE ) and certain of its ... had facilitated a "pump and dump" scheme to artificially ... trading period while the stock price was inflated, sold ...
(Date:8/31/2015)... 31, 2015  Regulatory affairs professionals work at ... are often strict and legislation is ever-changing. The ... for professionals who have a deep understanding of ... product lifecycle and demonstrate its use across various ... California, Irvine Extension , in partnership with the ...
(Date:8/31/2015)... Aug. 31, 2015 Regen BioPharma, Inc. (OTCBB: ... a novel means of delivering its patented (US ... liver tumors utilizing a clinically approved formulation as ... hurdles with gene silencing therapeutics in which the ... the whole body.  By utilizing a local delivery ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, Inc.,(Nasdaq:AVII) ... target patient enrollment and released six-month,follow-up data from ... trial, currently being held in Germany, was designed ... Resten-MP(TM), when,used in conjunction with the placement of ...
... Fail to Demonstrate Meaningful Placebo Adjusted Weight,Loss; ... July 09, 2007 /PRNewswire-FirstCall/ -- Manhattan,Pharmaceuticals, Inc. ... 2a clinical trials of oral Oleoyl-estrone (OE). ... one,in common obesity and the other in ...
Cached Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: